Vigilant Biosciences Inc.
www.vigilantbiosciences.com
Latest From Vigilant Biosciences Inc.
Medtech Execs On The Move, June 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Start-Up Execs On The Move, June 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Medical Device Deals Update, December 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced October-November 2015.
Deals Shaping The Medical Industry, December 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.
Company Information
- Industry
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
- Therapeutic Areas
- Cancer
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Vigilant Biosciences Inc.
- Senior Management
-
William Brodie, CEO
Robert T Hamilton, CFO
Elizabeth Franzmann, MD, CSO
David A Warar, VP, Bus. Dev. & International Markets - Contact Info
-
Vigilant Biosciences Inc.
Phone: (305) 728-5382
6301 NW 5th Way
Ste. 1500
Ft. Lauderdale, FL 33309
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice